Cancer

MHRA approves trofolastat for prostate cancer imaging

In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.

Redefining efficiency based on what matters to cancer patients

Redefining efficiency based on what matters to cancer patients is placed under the spotlight here by All.Can, including identifying opportunities for change.

Current gaps and future opportunities in dementia research

Here, Hilary Evans, Chief Executive at Alzheimer’s Research UK, outlines the current gaps and future opportunities in dementia research.

Vessel growth in health and disease

John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.

Functional nanomaterials: Fit for purpose

Researchers at Técnico, Univ. Lisboa, share their expertise on functional nanomaterials and why they are fit for purpose.

Paediatric Hepatitis B: Investigating fingernails and hair

Here, Haruki Komatsu discusses how Paediatric Hepatitis B virus (HBV) infection is one of the main things which can lead to liver cirrhosis and hepatocellular carcinoma.

Scientists discover way to protect hair from chemotherapy

Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.

UK launches £200 million genetics project

The UK government announced the launch of a huge genetics project, working with GlaxoSmithKline and AstraZeneca, to understand diseases like dementia and cancer.

New test could diagnose ovarian cancer up to two years earlier

A new test developed at Queen's University could allow ovarian cancer to be diagnosed at a stage up to two years earlier than current methods.

Cannabinoids in medicine Part 1: Cancer

In the first of a series of five articles, Oxford Cannabinoid Technologies will discuss their expertise on the medicinal use of cannabis derivatives.

Microfluidic devices: The future is here

Dr Stefan H. Bossmann and Dr Christopher T. Culbertson, Professors of Chemistry at Kansas State University, explain why microfluidic devices are in their view, the future.

NHS calls on A-level students to join the NHS

As nearly half a million students got their A-level results yesterday, NHS leaders are calling on young people to consider a career in nursing and join the NHS.

A devastating cancer: The priorities for brain tumour research

Chief Executive of Brain Tumour Research, Sue Farrington Smith MBE, outlines the priorities for research into brain tumours and why it is imperative we overcome this uniquely devastating cancer.

Preventing cancer: A whole-of-society, whole-of-government approach

World Cancer Research Fund’s Policy & Public Affairs Manager, Fiona Sing, outlines what governments and society should be doing to prevent cancer and other non-communicable diseases.

Scientists identify sea as how cancer spread 6,000 years ago

Researchers found out how cancer spread around the world, between sea-faring dogs around 6,000 years ago in Asia.

Cancer research in Japan: Basic, clinical and translational

Here, we examine the role of the Japanese Cancer Association (JCA) when it comes to the field of cancer research in Japan, including basic, clinical and translational.

Pharmacy and EPMA solution provider JAC renamed as WellSky

UK, JAC Computer Services Ltd has announced it has renamed as WellSky International Ltd.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders